Update: Influenza activity — United States, October 2, 2016–February 4, 2017

Morbidity and Mortality Weekly Report

Volumn 66, Issue 6, 2017, Pages 159-166

  Blanton, Lenee ^a   Mustaquim, Desiree ^a   Alabi, Noreen ^a   Kniss, Krista ^a   Kramer, Natalie ^a   Budd, Alicia ^a   Garg, Shikha ^a   Cummings, Charisse N ^a   Fry, Alicia M ^a   Bresee, Joseph ^a   Sessions, Wendy ^a   Garten, Rebecca ^a   Xu, Xiyan ^a   Elal, Anwar Isa Abd ^a   Gubareva, Larisa ^a   Barnes, John ^a   Wentworth, David E ^a   Burns, Erin ^a   Katz, Jacqueline ^a   Jernigan, Daniel ^a   Brammer, Lynnette ^a   more..

^a NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT;

ADOLESCENT; ADULT; AGED; ANTIVIRAL RESISTANCE; CHILD; CHILDHOOD MORTALITY; DRUG EFFECTS; FEMALE; GENETICS; HEALTH SURVEY; HOSPITALIZATION; HUMAN; INFANT; INFLUENZA A VIRUS (H1N1); INFLUENZA A VIRUS (H1N2); INFLUENZA A VIRUS (H3N2); INFLUENZA A VIRUS (H7N2); INFLUENZA B VIRUS; INFLUENZA, HUMAN; ISOLATION AND PURIFICATION; MALE; MIDDLE AGED; MORTALITY; NEWBORN; OUTPATIENT; PNEUMONIA; PREGNANCY; PRESCHOOL CHILD; SEASON; STATISTICS AND NUMERICAL DATA; UNITED STATES; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANTIVIRAL AGENTS; CHILD; CHILD MORTALITY; CHILD, PRESCHOOL; DRUG RESISTANCE, VIRAL; FEMALE; HOSPITALIZATION; HUMANS; INFANT; INFANT, NEWBORN; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H1N2 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA A VIRUS, H7N2 SUBTYPE; INFLUENZA B VIRUS; INFLUENZA, HUMAN; MALE; MIDDLE AGED; OUTPATIENTS; PNEUMONIA; POPULATION SURVEILLANCE; PREGNANCY; SEASONS; UNITED STATES; YOUNG ADULT;

EID: 85013661651     PISSN: 01492195     EISSN: 1545861X     Source Type: Journal    
DOI: 10.15585/mmwr.mm6606a2     Document Type: Note

References (5)

1. Shang M, Blanton L, Kniss K, et al. Update: influenza activity—United States, October 2-December 17, 2016. MMWR Morb Mortal Wkly Rep 2016;65:1439-44. http://dx.doi.org/10.15585/mmwr.mm655051a5
2. Flannery B, Chung J, Thaker S, et al. Interim estimates of 2016-17 seasonal influenza vaccine effectiveness—United States, February 2017. MMWR Morb Mortal Wkly Rep 2017;66:167-71.
3. Fiore AE, Fry A, Shay D, Gubareva L, Bresee JS, Uyeki TM. Antiviral agents for the treatment and chemoprophylaxis of influenza—recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2011;60(No. RR-1).
4. Food and Drug Administration. The FDA approves first generic version of widely used influenza drug, Tamiflu. Silver Spring, MD: US Department of Health and Human Services, Food and Drug Administration; 2016. http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm514854.htm
5. New York City Department of Health and Mental Hygiene. Health department investigation on H7N2 influenza in shelter cats confirms risk to humans is low. New York, NY: New York City Department of Health and Mental Hygiene; 2016. http://www1.nyc.gov/site/doh/about/press/pr2016/pr107-16.page